Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO

Benefit–Risk Assessment of Diacerein in the Treatment of Osteoarthritis

(2015) Elena Panova et al.   DRUG SAFETY

Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis

(2015) Olivier Bruyère et al.   DRUGS & AGING

OARSI guidelines for the non-surgical management of knee osteoarthritis

(2014) T.E. McAlindon et al.   OSTEOARTHRITIS AND CARTILAGE

An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

(2014) Olivier Bruyère et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Transplantation for Acute Liver Failure in Patients Exposed to NSAIDs or Paracetamol (Acetaminophen)

(2013) Sinem Ezgi Gulmez et al.   DRUG SAFETY

Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA# and GA2LEN/HANNA*

(2011) M. L. Kowalski et al.   ALLERGY

Diacerein as adjuvant to diclofenac sodium in osteoarthritis knee

(2011) Kuljinder SINGH et al.   International Journal of Rheumatic Diseases

Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies

(2011) Patricia McGettigan et al.   PLOS MEDICINE

Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis over a period of 10 years

(2011) DevinderMohan Thappa et al.   INDIAN JOURNAL OF DERMATOLOGY

OARSI recommendations for the management of hip and knee osteoarthritis

(2010) W. Zhang et al.   OSTEOARTHRITIS AND CARTILAGE

Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?

(2010) Fernando Bessone   WORLD JOURNAL OF GASTROENTEROLOGY

Effects of diacerein at the molecular level in the osteoarthritis disease process

(2010) Johanne Martel-Pelletier et al.   Therapeutic Advances in Musculoskeletal Disease

Efficacy and safety of diacerein in early knee osteoarthritis: a randomized placebo-controlled trial

(2009) Ballari Brahmachari et al.   CLINICAL RHEUMATOLOGY

Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials

(2009) E.M. Bartels et al.   OSTEOARTHRITIS AND CARTILAGE

Hospitalizations for Upper and Lower GI Events Associated With Traditional NSAIDs and Acetaminophen Among the Elderly in Quebec, Canada

(2008) Elham Rahme et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials

(2008) W Zhang et al.   ANNALS OF THE RHEUMATIC DISEASES

Diacerein inhibits the synthesis of resorptive enzymes and reduces osteoclastic differentiation/survival in osteoarthritic subchondral bone: a possible mechanism for a protective effect against subchondral bone remodelling

(2008) Christelle Boileau et al.   ARTHRITIS RESEARCH & THERAPY